Lycia Therapeutics, Inc. (LYCA)
Lycia Therapeutics, Inc. (LYCA) Insider Trading
Directors, officers and holders of more than 10% of LYCA report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 29 most recent of 29 transactions on file: 11 with code P, 0 with code S and 18 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 30, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 8,804 | $26.27 | $231,281 |
| Oct 30, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 200 | $26.86 | $5,372 |
| Oct 29, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 1,000 | $26.33 | $26,330 |
| Oct 28, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 10,570 | $25.23 | $266,681 |
| Oct 28, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 4,430 | $25.97 | $115,047 |
| Oct 27, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 31,067 | $26.84 | $833,838 |
| Oct 27, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 8,729 | $25.84 | $225,557 |
| Oct 26, 2026 | Versant Ventures VII GP, L.P. | 10% Owner | C Conversion | 6,284,597 | Not measured | Not measured |
| Oct 26, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | C Conversion | 4,408,091 | Not measured | Not measured |
| Oct 26, 2026 | Versant Ventures VII GP, L.P. | 10% Owner | C Conversion | 25,390,410 | Not measured | Not measured |
| Oct 26, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | C Conversion | 17,142,578 | Not measured | Not measured |
| Oct 26, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | C Conversion | 4,779,793 | Not measured | Not measured |
| Oct 26, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 1,944,444 | $18.00 | $34,999,992 |
| Oct 26, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 8,261 | $26.97 | $222,799 |
| Oct 26, 2026 | Versant Ventures VII GP, L.P. | 10% Owner | C Conversion | 5,631,425 | Not measured | Not measured |
| Oct 26, 2026 | Versant Ventures VII GP, L.P. | 10% Owner | C Conversion | 1,393,882 | Not measured | Not measured |
| Oct 23, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 24,560 | $25.68 | $630,701 |
| Oct 23, 2026 | Venrock Healthcare Capital Partners III, L.P. | 10% Owner | P Purchase | 28,379 | $26.11 | $740,976 |
| Oct 22, 2026 | RIEFLIN WILLIAM JL | Director | A Award | 20,000 | Not measured | Not measured |
| Oct 22, 2026 | Fischer Laurent | Director | A Award | 20,000 | Not measured | Not measured |
| Oct 22, 2026 | Henderson Jane | Director | A Award | 20,000 | Not measured | Not measured |
| Aug 11, 2026 | Fischer Laurent | Director | A Award | 13,307 | Not measured | Not measured |
| Aug 11, 2026 | Staben Steven | Chief Scientific Officer | A Award | 110,896 | Not measured | Not measured |
| Aug 11, 2026 | Lee Chin Hyok | Chief Medical Officer | A Award | 73,191 | Not measured | Not measured |
| Aug 11, 2026 | Bachrodt Amy | Chief Financial Officer | A Award | 399,746 | Not measured | Not measured |
| Aug 11, 2026 | Touami Sofia | Chief Business Officer | A Award | 68,755 | Not measured | Not measured |
| Aug 11, 2026 | Trombley Aetna Wun | President and CEO | A Award | 443,586 | Not measured | Not measured |
| Aug 11, 2026 | RIEFLIN WILLIAM JL | Director | A Award | 24,840 | Not measured | Not measured |
| Aug 11, 2026 | Henderson Jane | Director | A Award | 57,666 | Not measured | Not measured |
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.